case_images: PMC8432166_01
case_images: Chest x-ray performed on the first day and 24 hours after suspending dornase alfa therapy in patient A.
case_images: 1984-0462-rpp-40-e2020169-gf01.jpg
case_images: PMC8432166_01_1984-0462-rpp-40-e2020169-gf01.jpg
case_images: f1
case_images: Before the initiation of rhDNase, the x-ray had pulmonary atelectasis with a score of three (Figure 1A). The chest x-ray 24 hours after the extubation day is presented in Figure 1B, with a score of one.
case_images: PMC8432166_02
case_images: Chest x-ray performed on the first day and 24 hours after suspending dornase alfa therapy in patient B.
case_images: 1984-0462-rpp-40-e2020169-gf02.jpg
case_images: PMC8432166_02_1984-0462-rpp-40-e2020169-gf02.jpg
case_images: f2
case_images: At this time, her chest x-ray had a score of three (Figure 2A). The treatment was stopped at the extubation time, when the chest x-ray was normal - score of 0-1 (Figure 2B). Figure 3 shows the need for FiO2 of patients A and B during the PICU stay.
case_images: Fraction of inspired oxygen of patients A and B during the Pediatric Intensive Care Unit stay. Arrows indicate the start of dornase alfa administration.
case_images: 1984-0462-rpp-40-e2020169-gf03.jpg
case_images: PMC8432166_02_1984-0462-rpp-40-e2020169-gf03.jpg
case_images: f3
case_images: Figure 3 shows the need for FiO2 of patients A and B during the PICU stay.